Fabre success sees €71m production investment
French independent pharma group Pierre Fabre, which develops and markets dermatological cosmetic products, is to invest €71m at its Soual site in southern France. This will increase production capacity for skin cosmetics by 60 million units in the wake of rising international demand. A total of 475 people are currently employed at the site and this will increase by about 150.
French independent pharma group Pierre Fabre, which develops and markets dermatological cosmetic products, is to invest €71m at its Soual site in southern France. This will increase production capacity for skin cosmetics by 60 million units in the wake of rising international demand. A total of 475 people are currently employed at the site and this will increase by about 150.
The Soual unit makes creams, shampoos, lotions and gels sold under the Galenic, Klorane, Rene Furterer, Avene and Ducray brands. The project is scheduled for completion in the first half of 2010 and will be put into operation from mid-2011.